Carregant...
Apoptosis of cancer cells is triggered by selective crosslinking and inhibition of receptor tyrosine kinases
Receptor tyrosine kinases (RTK) have been the most prevalent therapeutic targets in anti-cancer drug development. However, the emergence of drug resistance toward single target RTK inhibitors remains a major challenge to achieve long-term remissions. Development of alternative RTK inhibitory strateg...
Guardat en:
| Publicat a: | Commun Biol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6588694/ https://ncbi.nlm.nih.gov/pubmed/31263775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-019-0484-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|